ProPhase Labs (PRPH) Announces Proposed Share Offering

Go back to ProPhase Labs (PRPH) Announces Proposed Share Offering

ProPhase Labs Announces Proposed Public Offering of Common Stock

November 7, 2024 4:06 PM UTC

GARDEN CITY, NY, Nov. 07, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a next-generation biotech, genomics and diagnostics company, today announced that it intends to offer to sell shares of its common stock (and/or pre-funded warrants (Pre-Funded Warrants) in lieu thereof) in an underwritten public offering. The Company expects to grant the underwriters a 45-day option to purchase up to an additional 15% of the number of shares of common stock and/or Pre-Funded Warrants sold in this offering to cover over-allotments, if any. All of the shares... More